
Indexed in
License and use
Analysis of institutional authors
Aguirre De Carcer Garcia, IñigoAuthorParra-Nieto J.AuthorBaeza ACorresponding AuthorInorganic Porous Nanoparticles for Drug Delivery in Antitumoral Therapy
Publicated to:Biotechnology Journal. 16 (2): e2000150- - 2021-01-01 16(2), DOI: 10.1002/biot.202000150
Authors: Parra-Nieto, Jorge; del Cid, Maria Amor Garcia; de Carcer, Inigo Aguirre; Baeza, Alejandro
Affiliations
Abstract
© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim The use of nanoparticles in oncology to deliver chemotherapeutic agents has received considerable attention in the last decades due to their tendency to be passively accumulated in solid tumors. Besides this remarkable property, the surface of these nanocarriers can be decorated with targeting moieties capable to recognize malignant cells which lead to selective nanoparticle uptake mainly in the diseased cells, without affecting the healthy ones. Among the different nanocarriers which have been developed with this purpose, inorganic porous nanomaterials constitute some of the most interesting due to their unique properties such as excellent cargo capacity, high biocompatibility and chemical, thermal and mechanical robustness, among others. Additionally, these materials can be engineered to present an exquisite control in the drug release behavior placing stimuli-responsive pore-blockers or sensitive hybrid coats on their surface. Herein, the recent advances developed in the use of porous inorganic nanomedicines will be described in order to provide an overview of their huge potential in the look out of an efficient and safe therapy against this complex disease. Porous inorganic nanoparticles have been designed to be accumulated in tumoral tissues; once there to recognize the target cell and finally, to release their payload in a controlled manner.
Keywords
Quality index
Bibliometric impact. Analysis of the contribution and dissemination channel
The work has been published in the journal Biotechnology Journal due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2021, it was in position 13/79, thus managing to position itself as a Q1 (Primer Cuartil), in the category Biochemical Research Methods.
From a relative perspective, and based on the normalized impact indicator calculated from World Citations provided by WoS (ESI, Clarivate), it yields a value for the citation normalization relative to the expected citation rate of: 3.82. This indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: ESI Nov 14, 2024)
This information is reinforced by other indicators of the same type, which, although dynamic over time and dependent on the set of average global citations at the time of their calculation, consistently position the work at some point among the top 50% most cited in its field:
- Weighted Average of Normalized Impact by the Scopus agency: 3.18 (source consulted: FECYT Feb 2024)
- Field Citation Ratio (FCR) from Dimensions: 7.63 (source consulted: Dimensions May 2025)
Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-05-31, the following number of citations:
- WoS: 48
- Scopus: 56
- OpenCitations: 55
Impact and social visibility
Leadership analysis of institutional authors
There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (PARRA NIETO, JORGE) and Last Author (Baeza Garcia, Alejandro).
the author responsible for correspondence tasks has been Baeza Garcia, Alejandro.